Off the wire
• Portugal detains man wanted by Germany to serve 10-year sentence  • Head of Latvian port authority to retire after being cleared of charges  • S. Africa edges up in 2016 corruption index  • Ghana's December PPI slumps to 4.9 pct  • Iranian FM terms Kuwait as "important" neighbor  • Portugal supports Serbia's EU accession: president  • Albania sees improvement in fighting corruption: official  • Ghana drops in corruption perception index in 2016  • News Analysis: Drought, strikes and polls to test Kenya's stability  • Macedonia, Malta establish diplomatic ties  
You are here: 　 Home

Britain to fund innovative healthcare technology development

Xinhua, January 26, 2017 Adjust font size:

Innovate UK announced Wednesday that government funding had been awarded to technology projects including an ultrasonic hologram, and treatment for hospital superbugs.

The funding aims to boost the development of innovative health care technologies.

Some 67 projects were selected to share the 26-million-pound (33 million U.S. dollar) funding available through Biomedical Catalyst 2016, which is run by Innovate UK and the Medical Research Council.

Among these projects, a Glasgow-based company will create ultrasonic holograms to diagnose sexually transmitted infections much more quickly than the current tests allow.

Another company is using antibodies produced by sheep to develop a treatment for antibiotic-resistant superbugs, such as Chlostridium difficle (C difficle).

In the autumn of 2016, Britain's Chancellor of the Exchequer Phillip Hammond announced 100 million pounds of additional funding to extend and enhance the Biomedical Catalyst to support life science companies and help medical technologies achieve commercial success. Endit